114 related articles for article (PubMed ID: 32565024)
1. SGK2 is overexpressed in colon cancer and promotes epithelial-mesenchymal transition in colon cancer cells.
Liu Y; Liu J; Kong X; Li H; Shao J; Jiang Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1912-1917. PubMed ID: 32565024
[TBL] [Abstract][Full Text] [Related]
2. SGK2 promotes hepatocellular carcinoma progression and mediates GSK-3β/β-catenin signaling in HCC cells.
Liu J; Zhang G; Lv Y; Zhang X; Ying C; Yang S; Kong X; Yu Y
Tumour Biol; 2017 Jun; 39(6):1010428317700408. PubMed ID: 28639896
[TBL] [Abstract][Full Text] [Related]
3. BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.
Zhang Y; Devocelle A; Desterke C; de Souza LEB; Hadadi É; Acloque H; Foudi A; Xiang Y; Ballesta A; Chang Y; Giron-Michel J
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065633
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoke extract modulates E-Cadherin, Claudin-1 and miR-21 and promotes cancer invasiveness in human colorectal adenocarcinoma cells.
Dino P; D'Anna C; Sangiorgi C; Di Sano C; Di Vincenzo S; Ferraro M; Pace E
Toxicol Lett; 2019 Dec; 317():102-109. PubMed ID: 31574306
[TBL] [Abstract][Full Text] [Related]
5. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
[TBL] [Abstract][Full Text] [Related]
6. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
9. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
10. PRP4 Kinase Domain Loss Nullifies Drug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells.
Ahmed MB; Islam SU; Sonn JK; Lee YS
Mol Cells; 2020 Jul; 43(7):662-670. PubMed ID: 32576716
[TBL] [Abstract][Full Text] [Related]
11. OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.
Xia L; Gao J; Ma K; Lin H; Chen Y; Luo Q; Lian J
Pathol Res Pract; 2021 Aug; 224():153493. PubMed ID: 34098198
[TBL] [Abstract][Full Text] [Related]
12. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer.
Saito S; Okabe H; Watanabe M; Ishimoto T; Iwatsuki M; Baba Y; Tanaka Y; Kurashige J; Miyamoto Y; Baba H
Oncol Rep; 2013 Apr; 29(4):1570-8. PubMed ID: 23404221
[TBL] [Abstract][Full Text] [Related]
13. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
14. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
15. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10.
Chu YM; Peng HX; Xu Y; Yang DM; Zhou FL; Li J; Kuai R; Lin Y
J Dig Dis; 2017 Mar; 18(3):169-178. PubMed ID: 28296190
[TBL] [Abstract][Full Text] [Related]
17. SGK2 promotes renal cancer progression via enhancing ERK 1/2 and AKT phosphorylation.
Liu Y; Chen JB; Zhang M; Zhang XL; Meng JL; Zhou J; Hao ZY; Zhang L; Zu XB; Liang CZ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2756-2767. PubMed ID: 31002126
[TBL] [Abstract][Full Text] [Related]
18. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
20. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
Wang J; Wang X; Liu F; Fu Y
Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
